Browsing by Author Tambaki, A. P.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 18 of 18
TitleAuthor(s)Issue date
Alterations in uric acid serum levels in laparoscopic procedures of upper abdomenGlantzounis, G. K.; Tsimaris, I.; Vasakos, S.; Tambaki, A. P.; Tselepis, A. D.; Galaris, D.; Tsimoyiannis, E. C.24-Nov-2015
Altered distribution of platelet-activating factor- acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemiaTsimihodimos, V.; Karabina, S. A.; Tambaki, A. P.; Bairaktari, E.; Miltiadous, G.; Goudevenos, J. A.; Cariolou, M. A.; Chapman, M. J.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemiaTsimihodimos, V.; Karabina, S. A. P.; Tambaki, A. P.; Bairaktari, E.; Miltiadous, G.; Goudevenos, J. A.; Cariolou, M. A.; Chapman, M. J.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIBTsimihodimos, V.; Karabina, S. A. P.; Tambaki, A. P.; Bairaktari, E.; Goudevenos, J. A.; Chapman, M. J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015
Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIBTsimihodimos, V.; Karabina, S. A.; Tambaki, A. P.; Bairaktari, E.; Goudevenos, J. A.; Chapman, M. J.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015
Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A(2)Saougos, V. G.; Tambaki, A. P.; Kalogirou, M.; Kostapanos, M.; Gazi, I. F.; Wolfert, R. L.; Elisaf, M.; Tselepis, A. D.24-Nov-2015
Effect of synthetic peptides corresponding to residues 313-332 of the alpha(IIb) subunit on platelet activation and fibrinogen binding to alpha(IIb)beta(3)Mitsios, J. V.; Tambaki, A. P.; Abatzis, M.; Biris, N.; Sakarellos-Daitsiotis, M.; Sakarellos, C.; Soteriadou, K.; Goudevenos, J.; Elisaf, M.; Tsoukatos, D.; Tsikaris, V.; Tselepis, A. D.24-Nov-2015
Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activityTambaki, A. P.; Rizos, E.; Tsimihodimos, V.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteinsTsimihodimos, V.; Kakafika, A.; Tambaki, A. P.; Bairaktari, E.; Chapman, M. J.; Elisaf, M.; Tselepis, A. D.24-Nov-2015
Lack of effect of acute repaglinide administration on postprandial lipaemia in patients with type 2 diabetes mellitusTentolouris, N.; Kolia, M.; Tselepis, A. D.; Perea, D.; Kitsou, E.; Kyriaki, D.; Tambaki, A. P.; Karabina, S. P.; Sala, C.; Fragoulopoulos, E.; Katsilambros, N.24-Nov-2015
Laparoscopic surgery-induced changes in oxidative stress markers in human plasmaGlantzounis, G. K.; Tselepis, A. D.; Tambaki, A. P.; Trikalinos, T. A.; Manataki, A. D.; Galaris, D. A.; Tsimoyiannis, E. C.; Kappas, A. M.24-Nov-2015
Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndromeRizos, E.; Tambaki, A. P.; Gazi, I.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapyTselepis, A. D.; Goudevenos, J. A.; Tambaki, A. P.; Michalis, L.; Stroumbis, C. S.; Tsoukatos, D. C.; Elisaf, M.; Sideris, D. A.24-Nov-2015
Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromesMichalis, L. K.; Tambaki, A. P.; Katsouras, C. S.; Goudevenos, J. A.; Kolettis, T.; Adamidis, K.; Tselepis, A. D.; Sideris, D. A.24-Nov-2015
The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activityKakafika, A. I.; Xenofontos, S.; Tsimihodimos, V.; Tambaki, A. P.; Lourida, E. S.; Kalaitzidis, R.; Cariolou, M. A.; Elisaf, M.; Tselepis, A. D.24-Nov-2015
Repaglinide reduces postprandial chylomicron-deficient plasma triglycerides in patients with type 2 diabetesTentolouris, N.; Kolia, M.; Tselepis, A. D.; Perea, D.; Kitsou, E.; Alevizou, V.; Tambaki, A. P.; Karabina, S. A. P.; Sala, C.; Fragoulopoulos, V.; Katsilambros, N.24-Nov-2015
Serum lipoprotein(a) concentrations and apolipoprotein(a) isoforms: association with the severity of clinical presentation in patients with coronary heart diseaseKatsouras, C. S.; Karabina, S. A.; Tambaki, A. P.; Goudevenos, J. A.; Michalis, L. K.; Tsironis, L. D.; Stroumbis, C. S.; Elisaf, M. S.; Sideris, D. A.; Tselepis, A. D.24-Nov-2015
Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effectMilionis, H. J.; Tambaki, A. P.; Kanioglou, C. N.; Elisaf, M. S.; Tselepis, A. D.; Tsatsoulis, A.24-Nov-2015